CCL11 levels at 24 hours after ischemic stroke were significantly associated with in-hospital mortality at patient discharge, and lower CCL11 levels predict stroke severity and can be used as a prognostic marker to predict acute and long-term functional impairment in ischemic stroke patients (Roy-O'Reilly et al., 2017). This evidence concerns the gene CCL11 and stroke disorder.